Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diagnosis of Myeloproliferative Neoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00089388
What this trial is testing

Cilengitide in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+9 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802161
What this trial is testing

Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Post Cytotoxic TherapyAcute Myeloid Leukemia With Multilineage Dysplasia+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT02215070
What this trial is testing

Pasireotide in Prevention of GI Toxicity

Who this might be right for
Hematological Malignancies
Anthony Sung, MD 37
Not applicableStudy completedNCT02121418
What this trial is testing

Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm

Who this might be right for
Chronic Myelomonocytic Leukemia-2Myelodysplastic SyndromeMyeloproliferative Neoplasm+1 more
University of Washington 12
Testing effectiveness (Phase 2)Study completedNCT00171223
What this trial is testing

An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha

Who this might be right for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Novartis Pharmaceuticals 532
Testing effectiveness (Phase 2)Active Not RecruitingNCT07789574
What this trial is testing

Efficacy of Asciminib in Chronic Phase CML Patients With T315I Mutations

Who this might be right for
Chronic Myeloid Leukemia (CML)
Thomas Ernst, PD Dr. med. 50
Not applicableStudy completedNCT00900380
What this trial is testing

Studying Tissue Samples to Learn More About Drug Resistance in Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
ECOG-ACRIN Cancer Research Group 40
Testing effectiveness (Phase 2)Ended earlyNCT00393380
What this trial is testing

Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor

Who this might be right for
Leukemia, Myeloid, ChronicAnemia, AplasticMyelofibrosis+5 more
The Emmes Company, LLC 13
Not applicableStudy completedNCT01475110
What this trial is testing

Observational Study in Adults With Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated With Nilotinib

Who this might be right for
Chronic Myeloid Leukaemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 19
Not applicableStudy completedNCT00988013
What this trial is testing

Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaLymphoblastic LeukemiaAcute Leukemia+2 more
University of Illinois at Chicago 14
Early research (Phase 1)Study completedNCT00083070
What this trial is testing

Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 16
Testing effectiveness (Phase 2)Study completedNCT00006225
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer

Who this might be right for
Breast CancerLeukemiaLymphoma+2 more
Northwestern University
Early research (Phase 1)Study completedNCT04609826
What this trial is testing

JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesChronic Myelomonocytic Leukemia
Janssen Research & Development, LLC 153
Early research (Phase 1)Study completedNCT01555268
What this trial is testing

Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+13 more
Roswell Park Cancer Institute 24
Large-scale testing (Phase 3)Study completedNCT03480360
What this trial is testing

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

Who this might be right for
Acute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Myeloid Leukemia+6 more
Dartmouth-Hitchcock Medical Center 21
Testing effectiveness (Phase 2)Study completedNCT01413568
What this trial is testing

Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in RemissionChronic Myelogenous Leukemia (CML)+5 more
Polyphor Ltd. 38
Testing effectiveness (Phase 2)Study completedNCT00305682
What this trial is testing

Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+1 more
Masonic Cancer Center, University of Minnesota 295
Not applicableStudy completedNCT05419648
What this trial is testing

Role of Monocytes Sub-populations in Thrombosis Associated With Myeloproliferative Neoplasms (MonSThr)

Who this might be right for
Myeloproliferative Neoplasm
University Hospital, Bordeaux 68
Testing effectiveness (Phase 2)Study completedNCT03075826
What this trial is testing

A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasms
Weill Medical College of Cornell University 22
Testing effectiveness (Phase 2)Study completedNCT00053248
What this trial is testing

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
OHSU Knight Cancer Institute 16
Next Page
49